WWW:NYSEWolverine World Wide, Inc. Analysis
Data as of 2026-06-29 - not real-time
$16.73
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
WWW is trading at $16.73, which sits below its 20‑day and 50‑day simple moving averages of 17.09 and 16.94, indicating short‑term pressure. The 200‑day SMA remains at 19.05, underscoring a longer‑term downtrend relative to current levels. Momentum is neutral with an RSI of 47, while the MACD histogram is negative and the signal line is bearish, suggesting limited upside in the immediate horizon. Volume has been stable, but price is hovering just above the identified support of 15.69 and well below resistance at 18.73. The stock’s beta of 1.42 and a 30‑day volatility of roughly 54% point to pronounced price swings. Despite these technical headwinds, the market sentiment index reads “Extreme Greed,” reflecting broader risk‑on appetite.
Fundamentally, WWW delivers an 11% revenue growth rate and a solid ROE of 29%, supporting its earnings outlook. The forward PE of 9.5 is well below the historical trailing PE of 13.6, indicating a value tilt. A discounted cash‑flow model places fair value at $17.11, implying roughly 30% upside from today’s price. The dividend yield of 2.33% with a payout ratio near 32% appears sustainable given strong operating cash flow. However, the company carries a high debt‑to‑equity ratio and has experienced a max drawdown of over 54%, adding leverage risk. Overall, the blend of attractive valuation, dividend income, and brand diversification makes the stock a compelling medium‑ to long‑term play.
Fundamentally, WWW delivers an 11% revenue growth rate and a solid ROE of 29%, supporting its earnings outlook. The forward PE of 9.5 is well below the historical trailing PE of 13.6, indicating a value tilt. A discounted cash‑flow model places fair value at $17.11, implying roughly 30% upside from today’s price. The dividend yield of 2.33% with a payout ratio near 32% appears sustainable given strong operating cash flow. However, the company carries a high debt‑to‑equity ratio and has experienced a max drawdown of over 54%, adding leverage risk. Overall, the blend of attractive valuation, dividend income, and brand diversification makes the stock a compelling medium‑ to long‑term play.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price near technical support with bearish MACD
- Neutral RSI and high short‑term volatility
- Stable trading volume but limited upside
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF fair value indicates ~30% upside
- Forward PE below 10 suggesting value appeal
- Sustainable dividend yield with low payout ratio
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong brand portfolio and revenue growth
- Robust ROE and cash flow generation
- Long‑term upside potential despite leverage
Key Metrics & Analysis
Financial Health
Revenue Growth11.00%
Profit Margin5.41%
P/E Ratio13.6
ROE29.24%
ROA6.22%
Debt/Equity181.32
P/B Ratio3.3
Op. Cash Flow$140.6M
Free Cash Flow$97.6M
Technical Analysis
TrendNeutral
RSI47.5
Support$15.69
Resistance$18.73
MA 20$17.09
MA 50$16.94
MA 200$19.05
MACDBearish
VolumeStable
Fear & Greed Index87.91
Valuation
Fair Value$17.11
Target Price$21.70
Upside/Downside29.71%
GradeUndervalued
TypeBlend
Dividend Yield2.33%
Risk Assessment
Beta1.42
Volatility53.86%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.